{"analyses":[{"ciLowerLimit":"0.20","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.52","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.2424","paramType":"Hazard Ratio (HR)","paramValue":"0.55","statisticalMethod":"Log Rank"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.71","upperLimit":"0.96","value":"0.90"},{"groupId":"OG001","lowerLimit":"0.74","upperLimit":"0.98","value":"0.93"}]}],"title":"6 months"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.56","upperLimit":"0.89","value":"0.77"},{"groupId":"OG001","lowerLimit":"0.70","upperLimit":"0.96","value":"0.89"}]}],"title":"12 months"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.48","upperLimit":"0.83","value":"0.69"},{"groupId":"OG001","lowerLimit":"0.65","upperLimit":"0.94","value":"0.85"}]}],"title":"18 months"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.48","upperLimit":"0.83","value":"0.69"},{"groupId":"OG001","lowerLimit":"0.61","upperLimit":"0.92","value":"0.81"}]}],"title":"24 months"}],"denoms":[{"counts":[{"groupId":"OG000","value":"30"},{"groupId":"OG001","value":"30"}],"units":"Participants"}],"description":"DFS was defined as the time from transplant to relapse or death due to any cause. If a patient had more than 1 event (e.g., relapse then death) then the earliest date was taken into account.","dispersionType":"95% Confidence Interval","groups":[{"description":"Patients received standard of care in the post stem cell transplant (SCT) setting in addition to Midostaurin 50mg twice a day for 12 months (cycles).","id":"OG000","title":"Standard of Care With Midostaurin"},{"description":"Patients received standard of care alone in the post SCT setting","id":"OG001","title":"Standard of Care"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"date of transplant up to 24 months","title":"Proportion of Participants With Relapse Free Survival (RFS) - Time From Randomization up to 24 Months(Full Analysis Set) by Kaplan-Meier Analysis","type":"SECONDARY","unitOfMeasure":"Proportion of participants"}